BOCA RATON, FL -- (MARKET WIRE) -- 10/06/2004 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), a leading manufacturer of Chinese herbs, veterinary medicines and low calorie natural sweetener in China, have announced that the Company will launch a new veterinary medicine research project incorporating elements of Nanotechnology. Nanotechnology will be employed as a screen for active components of Chinese veterinary medicine.

There are certain active components which are fundamental for the effectiveness of any Chinese medicine. Our goal is to isolate such active components by using Nanotechnology. The new Nanotechnology-based technique will allow us to screen these active components in a nanometer level. Eventually we hope to be able to determine the precise levels of the primary active components in these Chinese medicines which can lead to reduced production costs for future Chinese veterinary medicine products.

The Company's CEO, Baozhong Yuan, noted, "We continue to devote resources to research and development. This latest project will seek to apply the advances of Nanotechnology in veterinary medicine. Our intent is to establish Sunwin as a leading firm in the research and production of Chinese veterinary medicine."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. ("Sunwin") is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, nutraceutical products, natural sweetener (beet sugar), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more information about Sunwin, please visit http://www.shengwang.com.

Contact:
Pacific Rim Media for Sunwin International
Phone: 561-988-2242

SOURCE: Sunwin International Neutraceuticals, Inc.